{
    "code": "52026646",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52026646",
    "time": "2022-06-17 07:08:47",
    "許可證字號": "衛部藥輸字第026646號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "116\/08\/14",
    "發證日期": "106\/08\/14",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原登錄字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA05202664601",
    "中文品名": "佳瑞莎膜衣錠300毫克",
    "英文品名": "CAPRELSA Film-coated Tablets 300mg",
    "適應症": "無法進行手術切除的局部侵犯或轉移性甲狀腺髓質癌，並且為症狀性及疾病侵襲性的患者(aggressive and symptomatic medullary thyroid cancer (MTC) in patients with unresectable locally advanced or metastatic disease)",
    "劑型": "116膜衣錠",
    "包裝": "2-1000錠PVC\/PVDC鋁箔盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "111\/08\/14",
    "主成分略述": "Vandetanib",
    "限制項目": "02輸　入 1D須執行風險管理計畫 5F免除銜接性試驗",
    "申請商名稱": "1424601100  賽諾菲股份有限公司",
    "申請商地址": "台北市信義區松仁路3號7樓",
    "主製造廠": [
        {
            "製造廠名稱": "FGB0225000  PENN PHARMACEUTICAL SERVICES LIMITED",
            "製造廠廠址": "Units 23-24, Tafarnaubach Industrial Estate, Tredegar, Gwent, Wales, NP22 3AA, United Kingdom",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED KINGDOM",
            "製程": "分裝"
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "7770824858  台灣大昌華嘉股份有限公司",
            "製造廠廠址": "桃園市楊梅區梅獅路二段629號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": "包裝"
        },
        {
            "製造廠名稱": "FGB0200100  EUROAPI UK LIMITED",
            "製造廠廠址": "37 HOLLANDS ROAD, HAVERHILL, SUFFOLK, CB9 8PU, UNITED KINGDOM",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED KINGDOM",
            "製程": "包裝"
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1013004300",
            "成分名稱": "Vandetanib",
            "含量描述": "",
            "含量": "300.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "Caprelsa_LPI_C_USPI202006 (ref CCDS v3)_HA comment 2021.04.12 clean-110-04-16.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026646&Seq=003&Type=9"
        },
        {
            "title": "832888(iss1)-Caprelsa 300mg carton_28Oct'21 RA validated-110-11-03(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026646&Seq=003&Type=8"
        },
        {
            "title": "Caprelsa 300 Carton-106-09-18.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026646&Seq=002&Type=8"
        },
        {
            "title": "Caprelsa 300 Blister-106-09-18.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026646&Seq=001&Type=8"
        }
    ]
}